197 related articles for article (PubMed ID: 8195872)
1. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jun; 35(6):1067-75. PubMed ID: 8195872
[TBL] [Abstract][Full Text] [Related]
2. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake.
Kubota R; Kubota K; Yamada S; Tada M; Ido T; Tamahashi N
J Nucl Med; 1994 Jan; 35(1):104-12. PubMed ID: 8271030
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
J Nucl Med; 1992 Nov; 33(11):1972-80. PubMed ID: 1432158
[TBL] [Abstract][Full Text] [Related]
4. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG.
Kubota R; Kubota K; Yamada S; Tada M; Takahashi T; Iwata R; Tamahashi N
J Nucl Med; 1995 Mar; 36(3):484-92. PubMed ID: 7884515
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Reinhardt MJ; Kubota K; Yamada S; Iwata R; Yaegashi H
J Nucl Med; 1997 Feb; 38(2):280-7. PubMed ID: 9025756
[TBL] [Abstract][Full Text] [Related]
6. Tumor diagnosis by PET: potential of seven tracers examined in five experimental tumors including an artificial metastasis model.
Ishiwata K; Takahashi T; Iwata R; Tomura M; Tada M; Itoh J; Kameyama M; Ido T
Int J Rad Appl Instrum B; 1992 Aug; 19(6):611-8. PubMed ID: 1387872
[TBL] [Abstract][Full Text] [Related]
7. [Autoradiographic demonstration of 18F-FDG distribution within mouse FM3A tumor tissue in vivo].
Kubota R; Yamada S; Kubota K; Ishiwata K; Tamahashi N; Ido T
Kaku Igaku; 1992 Oct; 29(10):1215-21. PubMed ID: 1464961
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important?
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1995 Oct; 36(10):1854-61. PubMed ID: 7562055
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
10. Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
d'Argy R; Paul R; Frankenberg L; Stålnacke CG; Lundqvist H; Kangas L; Halldin C; Någren K; Roeda D; Haaparanta M
Int J Rad Appl Instrum B; 1988; 15(5):577-85. PubMed ID: 2978293
[TBL] [Abstract][Full Text] [Related]
11. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
[TBL] [Abstract][Full Text] [Related]
12. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.
Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T
J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging compared with carbon-11-L-methionine.
Kubota K; Ishiwata K; Kubota R; Yamada S; Takahashi J; Abe Y; Fukuda H; Ido T
J Nucl Med; 1996 Feb; 37(2):320-5. PubMed ID: 8667070
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Rasey JS; Hofstrand PD; Chin LK; Tewson TJ
J Nucl Med; 1999 Jun; 40(6):1072-9. PubMed ID: 10452326
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET evaluation of therapeutic effects on VX2 liver tumor.
Oya N; Nagata Y; Tamaki N; Takagi T; Murata R; Magata Y; Abe M; Konishi J
J Nucl Med; 1996 Feb; 37(2):296-302. PubMed ID: 8667065
[TBL] [Abstract][Full Text] [Related]
16. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Minn H; Clavo AC; Grénman R; Wahl RL
J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
[TBL] [Abstract][Full Text] [Related]
17. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.
Higashi K; Clavo AC; Wahl RL
J Nucl Med; 1993 Mar; 34(3):414-9. PubMed ID: 8441032
[TBL] [Abstract][Full Text] [Related]
18. Coincidence planar imaging for dynamic [18F]FDG uptake in nude mice with tumors and inflammation: correlated with histopathology and micro-autoradiography.
Sun YL; Jan ML; Kao PF; Fan KH; Hsu HT; Chang WC; Shen YC; Lee TW
Kaohsiung J Med Sci; 2005 Jun; 21(6):258-66. PubMed ID: 16035568
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for monitoring the response of tumors to radiotherapy in mice.
Murayama C; Harada N; Kakiuchi T; Fukumoto D; Kamijo A; Kawaguchi AT; Tsukada H
J Nucl Med; 2009 Feb; 50(2):290-5. PubMed ID: 19164228
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma.
Kaarstad K; Bender D; Bentzen L; Munk OL; Keiding S
J Nucl Med; 2002 Jul; 43(7):940-7. PubMed ID: 12097467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
